Fig. 4From: Impact of the COVID-19 pandemic on Bordetella pertussis infections in EnglandVaccine coverage for the prenatal pertussis vaccination programme, completed course of Hexavalent vaccine observed at 6 months from ImmForm and completed course of Hexavalent vaccine at 12 months from the COVER collection. †Prenatal pertussis vaccines coverage among pregnant women vaccinated up to 14 weeks prior to delivery. ††Prenatal pertussis vaccines coverage among pregnant women vaccinated up to 16 weeks prior to delivery and excluding miscarriages and stillbirths regardless of gestational age. †††Prenatal pertussis vaccines coverage among pregnant women vaccinated up to 26 weeks prior to delivery and excluding miscarriages and stillbirths regardless of gestational age. § Hexavalent vaccine coverage for 2014/15 estimates based on monthly extracts from June 2017 to March 2018. §§ Hexavalent vaccine coverage for 2021/22 estimates based on monthly extracts from April 2021 to June 2021Back to article page